Article
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
All News
Article
2020 evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was cooperatively developed the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR).
Article
Patients with rheumatic and inflammatory diseases who develop COVID-19 share risk factors for severe disease with the larger population, including older age, male sex, obesity, and hypertension, but also are at increased risk if they are on corticosteroids, French investigators reported.
Dr. John Cush
Tweet
Rheumatologists: Record your question or case for the RheumNow podcast.
https://t.co/wzNmOzH4VE https://t.co/wgiU30C2Ue
Dr. John Cush
Tweet
Who has more comorbidities? Dr. Janet Pope ( @Janetbirdope) reviews abstract #1466 presented at the #ACR20.
https://t.co/peJuRmH5rj https://t.co/WNLWkZQtLQ
Dr. John Cush
Tweet
Pregnancy Outcomes in AxSpa: Dr. Robert Chao ( @doctorRBC) reviews abstracts #1498, #1323 and #1324 presented at the #ACR20.
https://t.co/0N0FJh2WZd https://t.co/tbQjojlanu
Dr. John Cush
Tweet
Rheumatic Disease and COVID-19: Who Is at Risk?
https://t.co/dnD6127Ism
Dr. John Cush
Tweet
Listen to the latest RheumNow podcast, where we take listener questions.
https://t.co/RYqs25JuxS https://t.co/aYnTBj92DD
Dr. John Cush
Tweet
The EMA's CHMP has recommended upadacitinib (Rinvoq) as an indication for the treatment of adults with active Psoriatic Arthritis and Ankylosing Spondylitis. https://t.co/0PKm90mo7F
Dr. John Cush
Tweet
Mavrilimumab in Giant Cell Arteritis: Dr. Richard Conway ( @RichardPAConway)
#ACR20
https://t.co/kJgwfKjbrb https://t.co/MVqxKGE5jz
Dr. John Cush
Tweet
Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis ( @RADoctor) #ACR20
https://t.co/8YFjGslJ7E
Dr. John Cush
Tweet
Systemic Steroids Seldom Flare Psoriasis
https://t.co/14iz3l6CNf https://t.co/eiDXmoCitj
Dr. John Cush
Tweet
Antimalarials and Retinopathy: Dr. Janet Pope ( @Janetbirdope) #ACR20
https://t.co/6XqWxK8lCM https://t.co/YpDsEudGup
Dr. John Cush
Tweet
Olmstead County (Mayo) population study shows 47 lupus nephritis (LN) pts betw 1976-2018. Incidence doubled from 1980s (0.6 per 100K) to 2018 (1.2/100K); with women of childbearing age as the most affected group. #ACR20 Abstr#0274 https://t.co/a8GvILLse0 https://t.co/qlueI7LHc4
Dr. John Cush
Tweet
ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J
Dr. John Cush
Tweet
#FDA Pfizer presentation of their new COVID vaccine data https://t.co/Zk3DF3ycIF
Dr. John Cush
Tweet
Stop Making these mistakes because of COVID-19 Concerns:
1. Keep your medical appointments - Drs offices have changed to keep you SAFE
2. Get scheduled blood tests - LabCorp, Quest labs are very safe to go to
3. Restart usual scheduled visits,eye exams, bone density, annual PCP
Dr. John Cush
Tweet
Upadacitinib Effective in Biologic Refractory Psoriatic Arthritis #ACR20
https://t.co/uE4ZmfulbP https://t.co/OzpX6hLw6O
Dr. John Cush
Tweet
Taiwanese claims data on new RA (2003‐2016) shows decreasing incidence over time. After RA Dx the life expectancy was 26.3 yrs; lifetime cost US$ 72,953. On avg RA pts live 4.97 years less (historically this was 8-11yrs); has biologic era improved this? https://t.co/gHbZx1bw0A
Dr. John Cush
Tweet
Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush #ACR20
https://t.co/jOzAkLzNEc https://t.co/lPM8bbHDr7
